Compare CRDO & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRDO | HSIC |
|---|---|---|
| Founded | 2008 | 1932 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.2B | 8.8B |
| IPO Year | 2022 | 1995 |
| Metric | CRDO | HSIC |
|---|---|---|
| Price | $140.35 | $77.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $179.91 | $76.50 |
| AVG Volume (30 Days) | ★ 7.5M | 1.2M |
| Earning Date | 12-01-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.70 |
| EPS | 1.11 | ★ 3.17 |
| Revenue | $796,128,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $127.02 | $5.35 |
| Revenue Next Year | $28.18 | $3.34 |
| P/E Ratio | $126.25 | ★ $24.32 |
| Revenue Growth | ★ 224.17 | 3.51 |
| 52 Week Low | $29.09 | $60.56 |
| 52 Week High | $213.80 | $82.49 |
| Indicator | CRDO | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 39.38 | 67.76 |
| Support Level | $176.00 | $71.27 |
| Resistance Level | $213.80 | $77.46 |
| Average True Range (ATR) | 12.15 | 1.40 |
| MACD | -3.98 | 0.16 |
| Stochastic Oscillator | 4.20 | 91.65 |
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.